Literature DB >> 3363658

Deposition of nine metabolites of cyclosporine in human tissues, bile, urine, and whole blood.

G L Lensmeyer1, D A Wiebe, I H Carlson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3363658

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Isolation of 10 cyclosporine metabolites from human bile.

Authors:  C P Wang; N R Hartman; R Venkataramanan; I Jardine; F T Lin; J E Knapp; T E Starzl; G J Burckart
Journal:  Drug Metab Dispos       Date:  1989 May-Jun       Impact factor: 3.922

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition.

Authors:  Songmao Zheng; Yasar Tasnif; Mary F Hebert; Connie L Davis; Yoshihisa Shitara; Justina C Calamia; Yvonne S Lin; Danny D Shen; Kenneth E Thummel
Journal:  Transplantation       Date:  2013-03-27       Impact factor: 4.939

Review 5.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

Review 6.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

Review 8.  Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis.

Authors:  Xuerong Yang; Qi Li; Yuanyuan He; Yulian Zhu; Rou Yang; Xiaoshi Zhu; Xi Zheng; Wei Xiong; Yong Yang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.